Related Experiment Video
Updated: Dec 24, 2025

Subcutaneous Neurotrophin 4 Infusion Using Osmotic Pumps or Direct Muscular Injection Enhances Aging Rat Laryngeal Muscles
Published on: June 13, 2017
TNF Receptor-Associated Factor 6 Mediates TNFα-Induced Skeletal Muscle Atrophy in Mice During Aging
Jinbo Li1, Xiangjiao Yi1,2, Zhenqiang Yao1
1Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Abstract:
During aging, muscle mass decreases, leading to sarcopenia, associated with low-level chronic inflammation (inflammaging), which induces sarcopenia by promoting proteolysis of muscle fibers and inhibiting their regeneration. Patients with a variety of pathologic conditions associated with sarcopenia, including rheumatoid arthritis (RA), have systemically elevated TNFα serum levels, and transgenic mice with TNFα overexpression (TNF-Tg mice, a model of RA) develop sarcopenia between adolescence and adulthood before they age. However, if and how TNFα contributes to the pathogenesis of sarcopenia during the normal aging process and in RA remains largely unknown. We report that TNFα levels are increased in skeletal muscles of aged WT mice, associated with muscle atrophy and decreased numbers of satellite cells and Type IIA myofibers, a phenotype that we also observed in adult TNF-Tg mice. Aged WT mice also have increased numbers of myeloid lineage cells in their skeletal muscles, including macrophages and granulocytes. These cells have increased TNFα expression, which impairs myogenic cell differentiation. Expression levels of TNF receptor-associated factor 6 (TRAF6), an E3 ubiquitin ligase, which mediates signaling by some TNF receptor (TNFR) family members, are elevated in skeletal muscles of both aged WT mice and adult TNF-Tg mice. TRAF6 binds to TNFR2 in C2C12 myoblasts and mediates TNFα-induced muscle atrophy through NF-κB-induced transcription of the muscle-specific E3 ligases, Atrogen1 and Murf1, which promote myosin heavy-chain degradation. Haplo-deficiency of TRAF6 prevents muscle atrophy and the decrease in numbers of satellite cells, Type IIA myofibers, and myogenic regeneration in TRAF6+/- ;TNF-Tg mice. Our findings suggest that pharmacologic inhibition of TRAF6 signaling in skeletal muscles during aging could treat/prevent age- and RA-related sarcopenia by preventing TNFα-induced proteolysis and inhibition of muscle fiber regeneration. © 2020 American Society for Bone and Mineral Research.
Insights
Tumor Necrosis Factor-alpha (TNFα) drives age-related and rheumatoid arthritis (RA)-associated sarcopenia by increasing muscle proteolysis and impairing regeneration. Inhibiting TRAF6 signaling offers a potential therapeutic strategy for preventing muscle loss.
Area of Science:
- Muscle biology
- Immunology
- Aging research
Background:
- Sarcopenia, or age-related muscle loss, is linked to chronic inflammation (inflammaging).
- Elevated Tumor Necrosis Factor-alpha (TNFα) is observed in sarcopenia-associated conditions like rheumatoid arthritis (RA).
- The precise role of TNFα in aging and RA-related sarcopenia pathogenesis is unclear.
Purpose of the Study:
- To investigate the contribution of TNFα to sarcopenia during normal aging and in a mouse model of RA.
- To elucidate the molecular mechanisms by which TNFα induces muscle atrophy.
- To explore TRAF6 signaling as a potential therapeutic target.
Main Methods:
- Comparison of aged wild-type (WT) mice with transgenic (TNF-Tg) mice overexpressing TNFα.
- Analysis of skeletal muscle characteristics, including cell types, fiber composition, and protein degradation markers.
- Investigation of TNF receptor-associated factor 6 (TRAF6) signaling pathways and its role in TNFα-induced muscle atrophy.
- Assessment of the therapeutic potential of TRAF6 haplo-deficiency in preventing sarcopenia.
Main Results:
- Aged WT mice exhibited increased muscle TNFα, atrophy, reduced satellite cells, and fewer Type IIA myofibers, mirroring TNF-Tg mice.
- Myeloid cells, including macrophages, showed increased TNFα expression in aged muscles, impairing myogenic differentiation.
- TRAF6 expression was elevated in aged WT and TNF-Tg mice; TRAF6 mediated TNFα-induced atrophy via NF-κB and muscle-specific E3 ligases (Atrogen1, Murf1).
- TRAF6 haplo-deficiency in TNF-Tg mice ameliorated muscle atrophy and preserved muscle regeneration.
Conclusions:
- TNFα contributes significantly to sarcopenia in aging and RA.
- TRAF6 signaling is a key mediator of TNFα-induced muscle atrophy and regeneration inhibition.
- Pharmacologic inhibition of TRAF6 in skeletal muscle may offer a therapeutic approach for age- and RA-related sarcopenia.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

